EMA Committee for Medicinal Products for Human Use (CHMP) Adopts Positive Opinion Recommending Authorization for The Use of The Moderna Covid-19 Vaccine in Children (6-11 Years) In the European UnionAccesswire • 02/24/22
Moderna bucks market slump as it ups forecast for Covid-19 jab revenuesProactive Investors • 02/24/22
Moderna expects at least $19 billion in Covid vaccine sales in 2022, reports big fourth-quarter earnings beatCNBC • 02/24/22
Moderna Reports Fourth Quarter and Fiscal Year 2021 Financial Results and Provides Business UpdatesAccesswire • 02/24/22
Moderna Beats On Q4 Earnings, Announces $3B Buyback; Expects ~$19B In FY22 COVID-19 Vax SalesBenzinga • 02/24/22
Moderna Stock Crash Worsens Even After Morgan Stanley Says Flu Vaccine Results Could Boost SharesForbes • 02/23/22
CDC says waiting longer between Pfizer, Moderna doses may reduce rare myocarditis risk for younger menCNBC • 02/23/22
Moderna Stock Crash Steepens—But Expert Declares Incoming Flu Vaccine Results Could Show ‘Superiority'Forbes • 02/23/22
Moderna and Thermo Fisher enter long-term agreement on large-scale manufacturing of COVID vaccineMarket Watch • 02/23/22
Moderna and Thermo Fisher Scientific Announce Long-Term Strategic CollaborationBusiness Wire • 02/23/22
Moderna's Stock Setup To Recoup At Least Some Of Its $153 Billion In Lost Market CapForbes • 02/23/22
3 Ultra-Popular Stocks That Can Plummet Up to 65%, According to Wall StreetThe Motley Fool • 02/23/22